<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: This study was designed to examine the therapeutic effect of <z:chebi fb="0" ids="2376">acarbose</z:chebi> on serum <z:chebi fb="0" ids="17855">triglyceride</z:chebi> (TG), free fatty acid (FFA), <z:chebi fb="0" ids="39027">very low-density lipoprotein</z:chebi> (<z:chebi fb="1" ids="39027">VLDL</z:chebi>) and chylomicron (CM) in the meal tolerance test (<z:chebi fb="0" ids="53233">MTT</z:chebi>) before and after <z:chebi fb="0" ids="2376">acarbose</z:chebi> treatment in type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DM2</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Effects of <z:chebi fb="0" ids="2376">acarbose</z:chebi> on postprandial <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism were examined in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DM2</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>The subjects with normotriglyceridaemia (TG &gt; or = 1.7 mmol/l, n = 60) were divided to three groups (A, B and C), and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DM2</z:e> patients with hypertriglyceridaemia (TG &gt; 1.7 mmol/l, n = 20) were designated group D </plain></SENT>
<SENT sid="3" pm="."><plain>Group A was a control, and group B was designed to examine the one-dose effect of <z:chebi fb="0" ids="2376">acarbose</z:chebi> (100 mg) on <z:chebi fb="23" ids="18059">lipid</z:chebi> levels in <z:chebi fb="0" ids="53233">MTT</z:chebi> using the balanced food of 400 kcal </plain></SENT>
<SENT sid="4" pm="."><plain>In groups C and D, <z:chebi fb="0" ids="2376">acarbose</z:chebi> 300 mg/day was administered for 8 weeks, and <z:chebi fb="0" ids="53233">MTT</z:chebi> with the one-dose <z:chebi fb="0" ids="2376">acarbose</z:chebi> administration was performed </plain></SENT>
<SENT sid="5" pm="."><plain>We determined the levels of fasting and postprandial levels of <z:chebi fb="105" ids="17234">glucose</z:chebi>, insulin, FFA and TG-rich <z:chebi fb="2" ids="6495">lipoproteins</z:chebi> such as CM and <z:chebi fb="1" ids="39027">VLDL</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:chebi fb="0" ids="2376">Acarbose</z:chebi> treatment lowered plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> levels and insulin secretion </plain></SENT>
<SENT sid="7" pm="."><plain>In comparison among study groups A, B and C, <z:chebi fb="0" ids="2376">acarbose</z:chebi> significantly lowered serum TG levels in postprandial state </plain></SENT>
<SENT sid="8" pm="."><plain>In group D, after the 8-week <z:chebi fb="0" ids="2376">acarbose</z:chebi> administration, fasting or postprandial FFA, TG and <z:chebi fb="1" ids="39027">VLDL</z:chebi> levels were also lowered </plain></SENT>
<SENT sid="9" pm="."><plain>Interestingly, postprandial increase in CM was suppressed by <z:chebi fb="0" ids="2376">acarbose</z:chebi> administration in group B, C or D </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="2376">Acarbose</z:chebi> lowers postprandial TG and CM levels in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DM2</z:e> with either normotriglyceridaemia or hypertriglyceridaemia </plain></SENT>
<SENT sid="11" pm="."><plain>Improvement of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> with <z:chebi fb="0" ids="2376">acarbose</z:chebi> may also reduce fasting TG levels in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DM2</z:e> with hypertriglyceridaemia </plain></SENT>
<SENT sid="12" pm="."><plain><z:chebi fb="0" ids="2376">Acarbose</z:chebi> is a beneficial therapeutic agent to reduce TG levels in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DM2</z:e> patients, thereby leading to suppression of cardiovascular events </plain></SENT>
</text></document>